Aspira Pathlab & Diagnostics logo

Aspira Pathlab & Diagnostics share news and announcements

BSE: 540788Healthcare ServicesSmall Cap

Last close ₹126.05up ₹2.60 (2.11%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹123.45.

52-week range of traded prices to 23 Oct 2026
₹49.00Low, 15 Apr 2026₹149.99High, 30 Sep 2026
Market cap
₹130 Cr3,082nd largest listed
P/E
Lossover the last 12 months
P/B
10.6
Dividend yield
Nonein the last 12 months
ROE
−3.7%
ROCE
−4.4%
Debt to equity
0.11
Volume, BSE
352

Aspira Pathlab & Diagnostics share news and announcements

520 announcements, routine notices left out, newest first. Page 7 of 11.

  1. Jul 2021

    • 13 Jul · Shareholding for the Period Ended June 30, 2021

      Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....
    • 10 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021

      No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
    • 10 Jul · Updates Regarding Extension Of Scope Of NABL Accreditation

    • 2 Jul · Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligation & Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2021.

  2. Jun 2021

  3. May 2021

  4. Apr 2021

    • 20 Apr · Shareholding for the Period Ended March 31, 2021

      Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....
    • 13 Apr · Certificate Under Regulation 40(10) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2021

    • 9 Apr · Compliance-Compliance Certificate For Period Ended March 31, 2021

    • 9 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021

      No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
  5. Feb 2021

  6. Jan 2021

  7. Nov 2020

  8. Oct 2020

  9. Sep 2020